| 品牌 | 貨號 | 產品規格 | 價格(RMB) | 庫存（上海） | 北京 | 武漢 | 南京 | 購買數量 |
|---|---|---|---|---|---|---|---|---|
| 源葉(MedMol) | S81551-2mg | 98% | ￥240.00元 | 9 | - | - | - |
|
| 源葉(MedMol) | S81551-5mg | 98% | ￥384.00元 | 10 | - | - | - |
|
| 源葉(MedMol) | S81551-10mg | 98% | ￥720.00元 | 8 | - | - | - |
|
| 源葉(MedMol) | S81551-50mg | 98% | ￥2240.00元 | 7 | - | - | - |
|
| 源葉(MedMol) | S81551-100mg | 98% | ￥4080.00元 | 5 | - | - | - |
|
P005091 is a selective and potent inhibitor of ubiquitin-specific protease 7 (USP7) with an EC50 of 4.2 μM.
|
產品描述： P005091 is a selective and potent inhibitor of ubiquitin-specific protease 7 (USP7) with an EC50 of 4.2 μM. | ||||||||||||||||||||
| 靶點： EC50: 4.2 μM (USP7) | ||||||||||||||||||||
|
體內研究： In animal tumor model studies, P005091 is well tolerated, inhibits tumor growth, and prolongs survival. Combining P005091 with lenalidomide, HDAC inhibitor SAHA, or dexamethasone triggers synergistic anti-MM activity |
||||||||||||||||||||
|
參考文獻： 1. Chauhan D, et al. A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance. Cancer Cell. 2012 Sep 11;22(3):345-58. |
||||||||||||||||||||
| 溶解性： 1-Methyl-2-pyrrolidinone : 100 mg/mL (287.17 mM; Need ultrasonic) DMSO : 25 mg/mL (71.79 mM; Need ultrasonic) | ||||||||||||||||||||
| 保存條件： 2-8℃ | ||||||||||||||||||||
配置溶液濃度參考：
|
||||||||||||||||||||
| 注意： | 部分產品我司僅能提供部分信息，我司不保證所提供信息的權威性，僅供客戶參考交流研究之用。 |
|---|
上海工商
滬公網安備 31011702002021號
危險品化學品經營許可證（不帶存儲）
營業執照(三證合一)
北京